Speeding up hepatocyte proliferation: How triiodothyronine and β-catenin join forces

Hepatology

Volumn 59, Issue 6, 2014, Pages 2074-2076

  Gebhardt, Rolf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LIOTHYRONINE;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; GENE; HUMAN; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANIMALS; BETA CATENIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEPATOCYTES; LIVER REGENERATION; MALE; TRIIODOTHYRONINE;

EID: 84901420034     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26984     Document Type: Article

References (20)

1. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010;176:2-13.
2. Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol 2011;26(Suppl 1):203-212.
3. Raju R, Chau D, Verfaillie CM, Hu W. The road to regenerative liver therapies: the triumphs, trials and tribulations. Biotechnol Adv 2013;31:1085-1093.
4. Fanti M, Singh S, Ledda-Columbano GM, Columbano A, Monga SP. Triiodothyronine induces hepatocyte proliferation by protein kinase A-dependent -catenin activation in rodents. Hepatology 2014;59:2309-2320.
5. Francavilla A, Carr BI, Azzarone A, Polimeno L, Wang Z, van Thiel DH, et al. Hepatocyte proliferation and gene expression induced by triiodothyronine in vivo and in vitro. Hepatology 1994;20:1237-1241.
6. Bockhorn M, Frilling A, Benko T, Best J, Sheu S, Trippler M, et al. Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy. Eur Surg Res 2007;39:58-63.
7. Alisi A, Spagnuolo S, Napoletano S, Spaziani A, Leoni S. Thyroid hormones regulate DNA-synthesis and cell-cycle proteins by activation of PKCalpha and p42/44 MAPK in chick embryo hepatocytes. J Cell Physiol 2004;201:259-265.
8. Torres S, Diaz BP, Cabrera JJ, Diaz-Chico JC, Diaz-Chico BN, Lopez-Guerra A. Thyroid hormone regulation of rat hepatocyte proliferation and polyploidization. Am J Physiol 1999;276:G155-G163.
9. Kowalik MA, Perra A, Pibiri M, Cocco MT, Samarut J, Plateroti M, et al. TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells. J Hepatol 2010;53:686-692.
10. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-1142.
11. Davis PJ, Leonard JL, Davis FB. Mechanisms of nongenomic actions of thyroid hormone. Front Neuroendocrinol 2008;29:211-218.
12. Radenne A, Akpa M, Martel C, Sawadogo S, Mauvoisin D, Mounier C. Hepatic regulation of fatty acid synthase by insulin and T3: evidence for T3 genomic and nongenomic actions. Am J Physiol Endocrinol Metab 2008;295:E884-E894.
13. Nejak-Bowen KN, Monga SPS. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol 2011;21:44-58.
14. Gebhardt R, Hovhannisyan A. Organ patterning in the adult stage: the role of Wnt/beta-catenin signaling in liver zonation and beyond. Dev Dyn 2010;239:45-55.
15. Gebhardt R, Baldysiak-Figiel A, Krugel V, Ueberham E, Gaunitz F. Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem 2007;41:201-266.
16. Torre C, Benhamouche S, Mitchell C, Godard C, Veber P, Letourneur F, et al. The transforming growth factor-alpha and cyclin D1 genes are direct targets of beta-catenin signaling in hepatocyte proliferation. J Hepatol 2011;55:86-95.
17. Forbes SJ, Themis M, Alison MR, Selden C, Coutelle C, Hodgson HJ. Retroviral gene transfer to the liver in vivo during tri-iodothyronine induced hyperplasia. Gene Ther 1998;5:552-555.
18. Vasilj A, Gentzel M, Ueberham E, Gebhardt R, Shevchenko A. Tissue proteomics by one-dimensional gel electrophoresis combined with label-free protein quantification. J Proteome Res 2012;11:3680-3689.
19. Perra A, Simbula G, Simbula M, Pibiri M, Kowalik MA, Sulas P, et al. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J 2008;22:2981-2989.
20. Perra A, Kowalik MA, Pibiri M, Ledda-Columbano GM, Columbano A. Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype. Hepatology 2009;49:1287-1296.